These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3756852)

  • 1. Antibody-directed liposomes: comparison of various ligands for association, endocytosis, and drug delivery.
    Matthay KK; Heath TD; Badger CC; Bernstein ID; Papahadjopoulos D
    Cancer Res; 1986 Oct; 46(10):4904-10. PubMed ID: 3756852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific enhancement of drug delivery to AKR lymphoma by antibody-targeted small unilamellar vesicles.
    Matthay KK; Heath TD; Papahadjopoulos D
    Cancer Res; 1984 May; 44(5):1880-6. PubMed ID: 6713389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody-directed targeting of liposomes to human cell lines: role of binding and internalization on growth inhibition.
    Berinstein N; Matthay KK; Papahadjopoulos D; Levy R; Sikic BI
    Cancer Res; 1987 Nov; 47(22):5954-9. PubMed ID: 3664498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of ligand in antibody-directed endocytosis of liposomes by human T-leukemia cells.
    Matthay KK; Abai AM; Cobb S; Hong K; Papahadjopoulos D; Straubinger RM
    Cancer Res; 1989 Sep; 49(17):4879-86. PubMed ID: 2788031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of antibody isotype on passive serotherapy of lymphoma.
    Denkers EY; Badger CC; Ledbetter JA; Bernstein ID
    J Immunol; 1985 Sep; 135(3):2183-6. PubMed ID: 2862210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liposome-based therapy of human ovarian cancer: parameters determining potency of negatively charged and antibody-targeted liposomes.
    Straubinger RM; Lopez NG; Debs RJ; Hong K; Papahadjopoulos D
    Cancer Res; 1988 Sep; 48(18):5237-45. PubMed ID: 3409248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxicity of antibody-directed liposomes that recognize two receptors on K562 cells.
    Bragman KS; Heath TD; Papahadjopoulos D
    J Natl Cancer Inst; 1984 Jul; 73(1):127-31. PubMed ID: 6588220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. pH-sensitive immunoliposomes specific to the CD33 cell surface antigen of leukemic cells.
    Simard P; Leroux JC
    Int J Pharm; 2009 Nov; 381(2):86-96. PubMed ID: 19446624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of growth of leukemia cells in mice by monoclonal antibodies directed against Thy 1.1 antigen disulfide linked to two ribosomal inhibitors:pokeweed antiviral protein or ricin A chain.
    Ramakrishnan S; Houston LL
    Cancer Res; 1984 Apr; 44(4):1398-404. PubMed ID: 6142765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New methodology for liposome targeting to specific cells.
    Papahadjopoulos D; Heath T; Bragman K; Matthay K
    Ann N Y Acad Sci; 1985; 446():341-8. PubMed ID: 2861775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor effect of actinomycin D entrapped in liposomes bearing subunits of tumor-specific monoclonal immunoglobulin M antibody.
    Hashimoto Y; Sugawara M; Masuko T; Hojo H
    Cancer Res; 1983 Nov; 43(11):5328-34. PubMed ID: 6616468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug transfer into lymphoblasts mediated by liposomes bound to distinct sites on H-2 encoded I-A, I-E, and K molecules.
    Machy P; Pierres M; Barbet J; Leserman LD
    J Immunol; 1982 Nov; 129(5):2098-102. PubMed ID: 6811657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of mouse IgG2a- and IgG3-dependent cellular cytotoxicity in human monocytic cells (U937) by immune interferon.
    Akiyama Y; Lubeck MD; Steplewski Z; Koprowski H
    Cancer Res; 1984 Nov; 44(11):5127-31. PubMed ID: 6435864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocytosis and de novo expression of major histocompatibility complex encoded class I molecules: kinetic and ultrastructural studies.
    Machy P; Truneh A; Gennaro D; Hoffstein S
    Eur J Cell Biol; 1987 Dec; 45(1):126-36. PubMed ID: 3443107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of antitumor activity in mice for anti-epidermal growth factor receptor monoclonal antibodies with different isotypes.
    Masui H; Moroyama T; Mendelsohn J
    Cancer Res; 1986 Nov; 46(11):5592-8. PubMed ID: 3756906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo targeting of immunoliposomal doxorubicin to human B-cell lymphoma.
    Lopes de Menezes DE; Pilarski LM; Allen TM
    Cancer Res; 1998 Aug; 58(15):3320-30. PubMed ID: 9699662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liposomes containing alkylated methotrexate analogues for phospholipase A(2) mediated tumor targeted drug delivery.
    Kaasgaard T; Andresen TL; Jensen SS; Holte RO; Jensen LT; Jørgensen K
    Chem Phys Lipids; 2009 Feb; 157(2):94-103. PubMed ID: 19094974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibody-ricin A chain conjugate selectively cytotoxic for cells bearing the common acute lymphoblastic leukemia antigen.
    Raso V; Ritz J; Basala M; Schlossman SF
    Cancer Res; 1982 Feb; 42(2):457-64. PubMed ID: 6948605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uptake of antibody directed cytotoxic liposomes by CD3 on human T cells.
    Gray AG; Morgan J; Linch DC; Huehns ER
    Clin Exp Immunol; 1988 Apr; 72(1):168-73. PubMed ID: 3260836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental radiotherapy of murine lymphoma with 131I-labeled anti-Thy 1.1 monoclonal antibody.
    Badger CC; Krohn KA; Peterson AV; Shulman H; Bernstein ID
    Cancer Res; 1985 Apr; 45(4):1536-44. PubMed ID: 3978621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.